These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19509486)

  • 1. Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?
    Arnett DK; Claas SA; Lynch AI
    Curr Opin Cardiol; 2009 Jul; 24(4):333-9. PubMed ID: 19509486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies.
    Loganathan L; Gopinath K; Sankaranarayanan VM; Kukreti R; Rajendran K; Lee JK; Muthusamy K
    Curr Drug Targets; 2020; 21(1):18-33. PubMed ID: 31393243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive pharmacogenetics.
    Nogueira JB
    Rev Port Cardiol; 2004 Dec; 23(12):1621-30. PubMed ID: 15732663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension pharmacogenomics: in search of personalized treatment approaches.
    Cooper-DeHoff RM; Johnson JA
    Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of antihypertensive drug response.
    Kreutz R
    Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics considerations in the control of hypertension.
    Lupoli S; Salvi E; Barcella M; Barlassina C
    Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective.
    Kurland L
    Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of antihypertensive drug responses.
    Schwartz GL; Turner ST
    Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance.
    Arnett DK; Claas SA
    Pharmacogenomics; 2009 Aug; 10(8):1295-307. PubMed ID: 19663674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the pharmacogenetics of treating hypertension.
    Fontana V; Luizon MR; Sandrim VC
    J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive pharmacogenetics: getting the right drug into the right patient.
    Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E
    J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.
    Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR
    J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of hypertension.
    Cadman PE; O'Connor DT
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):61-70. PubMed ID: 12496668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic approaches to study the effects of antihypertensive drugs.
    Kamide K; Kawano Y; Rakugi H
    Hypertens Res; 2012 Aug; 35(8):796-9. PubMed ID: 22739423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of blood pressure response to antihypertensive treatment.
    Mellen PB; Herrington DM
    J Hypertens; 2005 Jul; 23(7):1311-25. PubMed ID: 15942450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system.
    Konoshita T;
    Curr Hypertens Rep; 2011 Oct; 13(5):356-61. PubMed ID: 21562941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.